Prospective Study for the Evaluation of the Cementless Anatomic Femoral Stem Minimax -Launay

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

ACTIVE_NOT_RECRUITING

Total Enrollment

100 participants

Study Classification

OBSERVATIONAL

Study Start Date

2019-01-02

Study Completion Date

2031-01-02

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This is a post-marketing surveillance on MiniMAX Stem

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Osseous Setting Improvement With Co-implantation of Osseous Matrix and Mesenchymal Progenitors Cells From Autologous Bone Marrow

NCT00557635

Tibia or Femur Pseudo-arthrosis

SUSPENDED PHASE2

Post Market Clinical Follow-Up Study for MicroPort PROFEMUR® Preserve Classic Femoral Stem

NCT04615039

Joint Diseases

WITHDRAWN

Long-term Observational Study of Subjects From Tanezumab Studies Who Undergo a Total Knee, Hip or Shoulder Replacement

NCT02674386

Osteoarthritis

COMPLETED PHASE3

Autologous Osteoblastic Cells Implantation to Early Stage Osteonecrosis of the Femoral Head

NCT02890537

Avascular Necrosis of Femur Head

COMPLETED PHASE2

Ambispective Multicentric Study Evaluating UKA With U-Knee/Uni-Kroma Implants

NCT05876143

Unicompartmental Knee Arthroplasty

RECRUITING

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Primary Osteoarthritis Secondary Osteoarthritis Traumatic Arthritis Rheumatoid Arthritis Congenital Hip Dysplasia Avascular Necrosis Fracture; Femur, Head

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

MiniMAX

Total or Partial Hip Arthroplasty

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

1. Patient with a clinical condition requiring THA
2. Patient receiving a MiniMAX® stem
3. Patient aged more than 18 years
4. Patient having a Social Insurance or a similar protection regime
5. Patient eligible for an AMIS procedure
6. Patient able to follow the study requirements
7. Patients who are willing to give informed written consent

Exclusion Criteria

1. Patient with local or systemic infection
2. Participation to biomedical research
3. Patient whose BMI exceeds 40
4. Patient with less than 18 years
5. Protected adults
6. Vulnerable person according to article L1121-6 of the Code de la Santè Publique.
7. Pregnant or lactating woman
8. Patient unable to express his/ her opinion about the participation to the study

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No